Sirnaomics' Series B Round

Sirnaomics raised a round of funding on April 28, 2016. Investors include Value Measured Investment Limited.

Sirnaomics (圣诺制药) has developed a portfolio of intellectual properties in therapeutic areas of interest including anti-fibrotic medicine, cancer therapeutics, and others. STP705 is an anti-fib…

Articles about Sirnaomics' Series B Round: